{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:40:26Z","timestamp":1793814026286,"version":"4.6.1"},"reference-count":246,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07075-0","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:42:10Z","timestamp":1759491730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Macrophage polarization in diabetic vascular complications: mechanistic insights and therapeutic targets"],"prefix":"10.1186","volume":"23","author":[{"given":"Liyuan","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinjing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zepeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"1","key":"7075_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.immuni.2014.06.013","volume":"41","author":"S Epelman","year":"2014","unstructured":"Epelman S, Lavine KJ, Randolph GJ. Origin and functions of tissue macrophages. Immunity. 2014;41(1):21\u201335.","journal-title":"Immunity"},{"key":"7075_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110945","volume":"204","author":"H Sun","year":"2023","unstructured":"Sun H, et al. Erratum to \u201cIDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045\u201d [Diabetes Res. Clin. Pract. 183 (2022) 109119]. Diabetes Res Clin Pract. 2023;204:110945.","journal-title":"Diabetes Res Clin Pract"},{"key":"7075_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","volume":"72","author":"JM Olefsky","year":"2010","unstructured":"Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010;72:219\u201346.","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"7075_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12933-023-02067-0","volume":"22","author":"D Wu","year":"2023","unstructured":"Wu D, et al. Combined effect of adiposity and elevated inflammation on incident type 2 diabetes: a prospective cohort study. Cardiovasc Diabetol. 2023;22(1):351.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"7075_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","volume":"55","author":"TV Rohm","year":"2022","unstructured":"Rohm TV, et al. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55(1):31\u201355.","journal-title":"Immunity"},{"issue":"1","key":"7075_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.immuni.2014.05.010","volume":"41","author":"JC McNelis","year":"2014","unstructured":"McNelis JC, Olefsky JM. Macrophages, immunity, and metabolic disease. Immunity. 2014;41(1):36\u201348.","journal-title":"Immunity"},{"issue":"9","key":"7075_CR7","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.2337\/db06-1650","volume":"56","author":"JA Ehses","year":"2007","unstructured":"Ehses JA, et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes. 2007;56(9):2356\u201370.","journal-title":"Diabetes"},{"issue":"2","key":"7075_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41574-019-0286-3","volume":"16","author":"W Ying","year":"2020","unstructured":"Ying W, et al. The role of macrophages in obesity-associated islet inflammation and \u03b2-cell abnormalities. Nat Rev Endocrinol. 2020;16(2):81\u201390.","journal-title":"Nat Rev Endocrinol"},{"issue":"13","key":"7075_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306685","volume":"11","author":"Y Liu","year":"2024","unstructured":"Liu Y, et al. Macrophage CREBZF orchestrates inflammatory response to potentiate insulin resistance and type 2 diabetes. Adv Sci (Weinh). 2024;11(13):e2306685.","journal-title":"Adv Sci (Weinh)"},{"key":"7075_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.746151","volume":"12","author":"S Russo","year":"2021","unstructured":"Russo S, et al. Meta-inflammation and metabolic reprogramming of macrophages in diabetes and obesity: the importance of metabolites. Front Immunol. 2021;12:746151.","journal-title":"Front Immunol"},{"issue":"3","key":"7075_CR11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s11892-007-0038-y","volume":"7","author":"MD Williams","year":"2007","unstructured":"Williams MD, Nadler JL. Inflammatory mechanisms of diabetic complications. Curr Diab Rep. 2007;7(3):242\u20138.","journal-title":"Curr Diab Rep"},{"key":"7075_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.redox.2018.09.025","volume":"20","author":"T Yuan","year":"2019","unstructured":"Yuan T, et al. New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol. 2019;20:247\u201360.","journal-title":"Redox Biol"},{"issue":"7","key":"7075_CR13","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0735-1097(03)00088-3","volume":"41","author":"GG Biondi-Zoccai","year":"2003","unstructured":"Biondi-Zoccai GG, et al. Atherothrombosis, inflammation, and diabetes. J Am Coll Cardiol. 2003;41(7):1071\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"7075_CR14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12964-022-01016-w","volume":"21","author":"C Xue","year":"2023","unstructured":"Xue C, et al. Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction. Cell Commun Signal. 2023;21(1):298.","journal-title":"Cell Commun Signal"},{"key":"7075_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1549945","volume":"16","author":"L Ma","year":"2025","unstructured":"Ma L, et al. Immune cell contribution to vascular complications in diabetes. Front Endocrinol (Lausanne). 2025;16:1549945.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"7075_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","volume":"9","author":"T Hu","year":"2024","unstructured":"Hu T, et al. Metabolic regulation of the immune system in health and diseases: mechanisms and interventions. Signal Transduct Target Ther. 2024;9(1):268.","journal-title":"Signal Transduct Target Ther"},{"issue":"7203","key":"7075_CR17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"R Medzhitov","year":"2008","unstructured":"Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428\u201335.","journal-title":"Nature"},{"issue":"2","key":"7075_CR18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","volume":"40","author":"J Xue","year":"2014","unstructured":"Xue J, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity. 2014;40(2):274\u201388.","journal-title":"Immunity"},{"key":"7075_CR19","doi-asserted-by":"crossref","unstructured":"Yan, L., et al., Macrophage plasticity: signaling pathways, tissue repair, and regeneration. MedComm (2020), 2024. 5(8): p. e658.","DOI":"10.1002\/mco2.658"},{"issue":"12","key":"7075_CR20","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.it.2023.10.004","volume":"44","author":"P Rodr\u00edguez-Morales","year":"2023","unstructured":"Rodr\u00edguez-Morales P, Franklin RA. Macrophage phenotypes and functions: resolving inflammation and restoring homeostasis. Trends Immunol. 2023;44(12):986\u201398.","journal-title":"Trends Immunol"},{"issue":"7966","key":"7075_CR21","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41586-023-06002-x","volume":"618","author":"T Lazarov","year":"2023","unstructured":"Lazarov T, et al. Physiology and diseases of tissue-resident macrophages. Nature. 2023;618(7966):698\u2013707.","journal-title":"Nature"},{"issue":"1","key":"7075_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41392-025-02124-y","volume":"10","author":"F Guan","year":"2025","unstructured":"Guan F, et al. Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets. Signal Transduct Target Ther. 2025;10(1):93.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"7075_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","volume":"38","author":"S Yona","year":"2013","unstructured":"Yona S, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity. 2013;38(1):79\u201391.","journal-title":"Immunity"},{"issue":"6917","key":"7075_CR24","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nature01320","volume":"420","author":"C Nathan","year":"2002","unstructured":"Nathan C. Points of control in inflammation. Nature. 2002;420(6917):846\u201352.","journal-title":"Nature"},{"issue":"6161","key":"7075_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/science.1242974","volume":"342","author":"MH Sieweke","year":"2013","unstructured":"Sieweke MH, Allen JE. Beyond stem cells: self-renewal of differentiated macrophages. Science. 2013;342(6161):1242974.","journal-title":"Science"},{"issue":"7","key":"7075_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T van der Poll","year":"2017","unstructured":"van der Poll T, et al. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17(7):407\u201320.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"7075_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","volume":"7","author":"P Kong","year":"2022","unstructured":"Kong P, et al. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduct Target Ther. 2022;7(1):131.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"7075_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103820","volume":"24","author":"S Wu","year":"2025","unstructured":"Wu S, et al. Macrophage polarization regulates the pathogenesis and progression of autoimmune diseases. Autoimmun Rev. 2025;24(7):103820.","journal-title":"Autoimmun Rev"},{"key":"7075_CR29","doi-asserted-by":"publisher","first-page":"1352946","DOI":"10.3389\/fimmu.2024.1352946","volume":"15","author":"M Luo","year":"2024","unstructured":"Luo M, et al. Macrophage polarization: an important role in inflammatory diseases. Front Immunol. 2024;15:1352946.","journal-title":"Front Immunol"},{"issue":"4","key":"7075_CR30","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.jaci.2018.12.995","volume":"143","author":"MC Bosco","year":"2019","unstructured":"Bosco MC. Macrophage polarization: Reaching across the aisle? J Allergy Clin Immunol. 2019;143(4):1348\u201350.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"7075_CR31","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122(3):787\u201395.","journal-title":"J Clin Invest"},{"key":"7075_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","volume":"15","author":"M Locati","year":"2020","unstructured":"Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol. 2020;15:123\u201347.","journal-title":"Annu Rev Pathol"},{"issue":"12","key":"7075_CR33","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8(12):958\u201369.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"7075_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14\u201320.","journal-title":"Immunity"},{"issue":"4","key":"7075_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.smim.2015.10.003","volume":"27","author":"C Porta","year":"2015","unstructured":"Porta C, et al. Molecular and epigenetic basis of macrophage polarized activation. Semin Immunol. 2015;27(4):237\u201348.","journal-title":"Semin Immunol"},{"issue":"4","key":"7075_CR36","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.smim.2015.09.001","volume":"27","author":"KC El Kasmi","year":"2015","unstructured":"El Kasmi KC, Stenmark KR. Contribution of metabolic reprogramming to macrophage plasticity and function. Semin Immunol. 2015;27(4):267\u201375.","journal-title":"Semin Immunol"},{"issue":"3","key":"7075_CR37","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1124\/pharmrev.121.000349","volume":"74","author":"LGN de Almeida","year":"2022","unstructured":"de Almeida LGN, et al. Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology. Pharmacol Rev. 2022;74(3):712\u201368.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"7075_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen S, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther. 2023;8(1):207.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"7075_CR39","doi-asserted-by":"publisher","first-page":"520","DOI":"10.7150\/ijbs.8879","volume":"10","author":"YC Liu","year":"2014","unstructured":"Liu YC, et al. Macrophage polarization in inflammatory diseases. Int J Biol Sci. 2014;10(5):520\u20139.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"7075_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nri978","volume":"3","author":"S Gordon","year":"2003","unstructured":"Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3(1):23\u201335.","journal-title":"Nat Rev Immunol"},{"key":"7075_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cells13181586","author":"K Kulakova","year":"2024","unstructured":"Kulakova K, et al. The contribution of macrophage plasticity to inflammatory arthritis and their potential as therapeutic targets. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13181586.","journal-title":"Cells"},{"key":"7075_CR42","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-immunol-032712-095906","volume":"31","author":"SJ Van Dyken","year":"2013","unstructured":"Van Dyken SJ, Locksley RM. Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol. 2013;31:317\u201343.","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"7075_CR43","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","volume":"32","author":"S Gordon","year":"2010","unstructured":"Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010;32(5):593\u2013604.","journal-title":"Immunity"},{"key":"7075_CR44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.lfs.2019.03.062","volume":"224","author":"R Shrivastava","year":"2019","unstructured":"Shrivastava R, Shukla N. Attributes of alternatively activated (M2) macrophages. Life Sci. 2019;224:222\u201331.","journal-title":"Life Sci"},{"issue":"1","key":"7075_CR45","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s10020-024-00866-z","volume":"30","author":"L Zhao","year":"2024","unstructured":"Zhao L, et al. Regulation of macrophage polarization by targeted metabolic reprogramming for the treatment of lupus nephritis. Mol Med. 2024;30(1):96.","journal-title":"Mol Med"},{"issue":"Pt A","key":"7075_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109260","volume":"113","author":"Y Xie","year":"2022","unstructured":"Xie Y, et al. Novel insight on the role of macrophages in atherosclerosis: focus on polarization, apoptosis and efferocytosis. Int Immunopharmacol. 2022;113(Pt A):109260.","journal-title":"Int Immunopharmacol"},{"issue":"18","key":"7075_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100275","volume":"8","author":"S Demir","year":"2021","unstructured":"Demir S, et al. Emerging targets in type 2 diabetes and diabetic complications. Adv Sci (Weinh). 2021;8(18):e2100275.","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"7075_CR48","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3109\/07853890.2011.585346","volume":"44","author":"T Nishizawa","year":"2012","unstructured":"Nishizawa T, Bornfeldt KE. Diabetic vascular disease and the potential role of macrophage glucose metabolism. Ann Med. 2012;44(6):555\u201363.","journal-title":"Ann Med"},{"issue":"763","key":"7075_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adn1507","volume":"16","author":"TT Chang","year":"2024","unstructured":"Chang TT, et al. Inhibition of CCL7 improves endothelial dysfunction and vasculopathy in mouse models of diabetes mellitus. Sci Transl Med. 2024;16(763):eadn1507.","journal-title":"Sci Transl Med"},{"issue":"5 Suppl","key":"7075_CR50","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/j.jacc.2008.09.055","volume":"53","author":"G Orasanu","year":"2009","unstructured":"Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol. 2009;53(5 Suppl):S35-42.","journal-title":"J Am Coll Cardiol"},{"key":"7075_CR51","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cytogfr.2024.07.005","volume":"78","author":"FH Shah","year":"2024","unstructured":"Shah FH, Lee HW. Endothelial and macrophage interactions in the angiogenic niche. Cytokine Growth Factor Rev. 2024;78:64\u201376.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"7","key":"7075_CR52","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1210\/er.2008-0024","volume":"29","author":"MA Cornier","year":"2008","unstructured":"Cornier MA, et al. The metabolic syndrome. Endocr Rev. 2008;29(7):777\u2013822.","journal-title":"Endocr Rev"},{"issue":"5","key":"7075_CR53","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s00125-015-3525-8","volume":"58","author":"B Verg\u00e8s","year":"2015","unstructured":"Verg\u00e8s B. Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia. 2015;58(5):886\u201399.","journal-title":"Diabetologia"},{"key":"7075_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020804","author":"G Jia","year":"2024","unstructured":"Jia G, et al. Diabetic vasculopathy: molecular mechanisms and clinical insights. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25020804.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"7075_CR55","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.atherosclerosis.2010.01.028","volume":"211","author":"B Verg\u00e8s","year":"2010","unstructured":"Verg\u00e8s B. Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes. Atherosclerosis. 2010;211(2):353\u201360.","journal-title":"Atherosclerosis"},{"key":"7075_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061680","author":"NKP Wong","year":"2018","unstructured":"Wong NKP, et al. The role of high-density lipoproteins in diabetes and its vascular complications. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19061680.","journal-title":"Int J Mol Sci"},{"key":"7075_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112622","volume":"138","author":"H Kang","year":"2024","unstructured":"Kang H, Song J, Cheng Y. HDL regulates the risk of cardiometabolic and inflammatory-related diseases: focusing on cholesterol efflux capacity. Int Immunopharmacol. 2024;138:112622.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"7075_CR58","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.cardiores.2004.05.001","volume":"63","author":"G Basta","year":"2004","unstructured":"Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res. 2004;63(4):582\u201392.","journal-title":"Cardiovasc Res"},{"issue":"17","key":"7075_CR59","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.1021\/acs.jmedchem.7b00058","volume":"60","author":"S Bongarzone","year":"2017","unstructured":"Bongarzone S, et al. Targeting the receptor for advanced glycation endproducts (RAGE): a medicinal chemistry perspective. J Med Chem. 2017;60(17):7213\u201332.","journal-title":"J Med Chem"},{"issue":"12","key":"7075_CR60","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1161\/01.CIR.0000091257.27563.32","volume":"108","author":"MA Creager","year":"2003","unstructured":"Creager MA, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation. 2003;108(12):1527\u201332.","journal-title":"Circulation"},{"key":"7075_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158582","author":"FF Jubaidi","year":"2022","unstructured":"Jubaidi FF, et al. The role of PKC-MAPK signalling pathways in the development of hyperglycemia-induced cardiovascular complications. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23158582.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7075_CR62","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, et al. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc Diabetol. 2018;17(1):83.","journal-title":"Cardiovasc Diabetol"},{"key":"7075_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"7075_CR64","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00125-020-05319-w","volume":"64","author":"N Nanayakkara","year":"2021","unstructured":"Nanayakkara N, et al. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses. Diabetologia. 2021;64(2):275\u201387.","journal-title":"Diabetologia"},{"issue":"1","key":"7075_CR65","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s10020-024-00824-9","volume":"30","author":"T Yang","year":"2024","unstructured":"Yang T, et al. An update on chronic complications of diabetes mellitus: from molecular mechanisms to therapeutic strategies with a focus on metabolic memory. Mol Med. 2024;30(1):71.","journal-title":"Mol Med"},{"key":"7075_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051835","author":"A Poznyak","year":"2020","unstructured":"Poznyak A, et al. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21051835.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7075_CR67","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/s41467-024-45582-8","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, et al. Palmitic acid in type 2 diabetes mellitus promotes atherosclerotic plaque vulnerability via macrophage Dll4 signaling. Nat Commun. 2024;15(1):1281.","journal-title":"Nat Commun"},{"issue":"5","key":"7075_CR68","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","volume":"14","author":"KE Bornfeldt","year":"2011","unstructured":"Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14(5):575\u201385.","journal-title":"Cell Metab"},{"key":"7075_CR69","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3389\/fimmu.2016.00275","volume":"7","author":"M de Gaetano","year":"2016","unstructured":"de Gaetano M, et al. M1- and M2-type macrophage responses are predictive of adverse outcomes in human atherosclerosis. Front Immunol. 2016;7:275.","journal-title":"Front Immunol"},{"key":"7075_CR70","doi-asserted-by":"publisher","first-page":"1185587","DOI":"10.3389\/fimmu.2023.1185587","volume":"14","author":"J Wu","year":"2023","unstructured":"Wu J, et al. Macrophage polarization states in atherosclerosis. Front Immunol. 2023;14:1185587.","journal-title":"Front Immunol"},{"issue":"1","key":"7075_CR71","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00395-023-01023-z","volume":"119","author":"I Gianopoulos","year":"2024","unstructured":"Gianopoulos I, Daskalopoulou SS. Macrophage profiling in atherosclerosis: understanding the unstable plaque. Basic Res Cardiol. 2024;119(1):35\u201356.","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"7075_CR72","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s11892-012-0270-y","volume":"12","author":"R Puri","year":"2012","unstructured":"Puri R, et al. The distinctive nature of atherosclerotic vascular disease in diabetes: pathophysiological and morphological insights. Curr Diab Rep. 2012;12(3):280\u20135.","journal-title":"Curr Diab Rep"},{"issue":"11","key":"7075_CR73","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1161\/CIRCRESAHA.116.306923","volume":"118","author":"MS Shah","year":"2016","unstructured":"Shah MS, Brownlee M. Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes. Circ Res. 2016;118(11):1808\u201329.","journal-title":"Circ Res"},{"issue":"1 Suppl","key":"7075_CR74","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.10.013","volume":"122","author":"W Insull Jr","year":"2009","unstructured":"Insull W Jr. The pathology of atherosclerosis: plaque development and plaque responses to medical treatment. Am J Med. 2009;122(1 Suppl):S3-s14.","journal-title":"Am J Med"},{"issue":"8 Suppl","key":"7075_CR75","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","volume":"47","author":"E Falk","year":"2006","unstructured":"Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006;47(8 Suppl):C7-12.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"7075_CR76","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","volume":"185","author":"JLM Bj\u00f6rkegren","year":"2022","unstructured":"Bj\u00f6rkegren JLM, Lusis AJ. Atherosclerosis: recent developments. Cell. 2022;185(10):1630\u201345.","journal-title":"Cell"},{"issue":"4","key":"7075_CR77","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.7150\/thno.105256","volume":"15","author":"F Fang","year":"2025","unstructured":"Fang F, et al. Macrophage-based pathogenesis and theranostics of vulnerable plaques. Theranostics. 2025;15(4):1570\u201388.","journal-title":"Theranostics"},{"issue":"12","key":"7075_CR78","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/j.jcmg.2023.08.006","volume":"16","author":"G Gallone","year":"2023","unstructured":"Gallone G, et al. Coronary plaque characteristics associated with major adverse cardiovascular events in atherosclerotic patients and lesions: a systematic review and meta-analysis. JACC Cardiovasc Imaging. 2023;16(12):1584\u2013604.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"19","key":"7075_CR79","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1093\/eurheartj\/ehab920","volume":"43","author":"A Edsfeldt","year":"2022","unstructured":"Edsfeldt A, et al. Interferon regulatory factor-5-dependent CD11c+ macrophages contribute to the formation of rupture-prone atherosclerotic plaques. Eur Heart J. 2022;43(19):1864\u201377.","journal-title":"Eur Heart J"},{"issue":"2","key":"7075_CR80","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2012.09.013","volume":"225","author":"JL St\u00f6ger","year":"2012","unstructured":"St\u00f6ger JL, et al. Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis. 2012;225(2):461\u20138.","journal-title":"Atherosclerosis"},{"issue":"8","key":"7075_CR81","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1161\/CIRCRESAHA.110.233775","volume":"108","author":"G Chinetti-Gbaguidi","year":"2011","unstructured":"Chinetti-Gbaguidi G, et al. Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPAR\u03b3 and LXR\u03b1 pathways. Circ Res. 2011;108(8):985\u201395.","journal-title":"Circ Res"},{"key":"7075_CR82","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cca.2019.10.034","volume":"501","author":"S Yang","year":"2020","unstructured":"Yang S, et al. Macrophage polarization in atherosclerosis. Clin Chim Acta. 2020;501:142\u20136.","journal-title":"Clin Chim Acta"},{"key":"7075_CR83","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3389\/fimmu.2014.00579","volume":"5","author":"M Peled","year":"2014","unstructured":"Peled M, Fisher EA. Dynamic Aspects of Macrophage Polarization during Atherosclerosis Progression and Regression. Front Immunol. 2014;5:579.","journal-title":"Front Immunol"},{"issue":"1","key":"7075_CR84","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/imr.12218","volume":"262","author":"S Colin","year":"2014","unstructured":"Colin S, Chinetti-Gbaguidi G, Staels B. Macrophage phenotypes in atherosclerosis. Immunol Rev. 2014;262(1):153\u201366.","journal-title":"Immunol Rev"},{"issue":"1","key":"7075_CR85","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1315","volume":"33","author":"N Satoh","year":"2010","unstructured":"Satoh N, et al. Unbalanced M1\/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone. Diabetes Care. 2010;33(1):e7.","journal-title":"Diabetes Care"},{"issue":"11","key":"7075_CR86","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1111\/jcmm.13814","volume":"22","author":"E Pardali","year":"2018","unstructured":"Pardali E, et al. BMP-2 induces human mononuclear cell chemotaxis and adhesion and modulates monocyte-to-macrophage differentiation. J Cell Mol Med. 2018;22(11):5429\u201338.","journal-title":"J Cell Mol Med"},{"key":"7075_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.110878","volume":"514","author":"X Han","year":"2020","unstructured":"Han X, et al. Advanced glycation end products enhance macrophage polarization to the M1 phenotype via the HIF-1\u03b1\/PDK4 pathway. Mol Cell Endocrinol. 2020;514:110878.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"7075_CR88","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12933-018-0763-3","volume":"17","author":"R Kaur","year":"2018","unstructured":"Kaur R, Kaur M, Singh J. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovasc Diabetol. 2018;17(1):121.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"7075_CR89","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00395-011-0237-1","volume":"107","author":"H Zhang","year":"2012","unstructured":"Zhang H, Dellsperger KC, Zhang C. The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update. Basic Res Cardiol. 2012;107(1):237.","journal-title":"Basic Res Cardiol"},{"key":"7075_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154667","volume":"112","author":"W Sha","year":"2023","unstructured":"Sha W, et al. Astragalus polysaccharide ameliorates vascular endothelial dysfunction by stimulating macrophage M2 polarization via potentiating Nrf2\/HO-1 signaling pathway. Phytomedicine. 2023;112:154667.","journal-title":"Phytomedicine"},{"issue":"1","key":"7075_CR91","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10565-024-09973-3","volume":"41","author":"G Chen","year":"2025","unstructured":"Chen G, et al. Exosomal NEDD4L derived from HG+oxLDL-induced vascular endothelial cells accelerates macrophage M1 polarization and oxLDL uptake by ubiquitinating I\u03baB\u03b1 and PPAR\u03b3. Cell Biol Toxicol. 2025;41(1):23.","journal-title":"Cell Biol Toxicol"},{"key":"7075_CR92","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6668506","volume":"2021","author":"BA Di Bartolo","year":"2021","unstructured":"Di Bartolo BA, et al. HDL improves cholesterol and glucose homeostasis and reduces atherosclerosis in diabetes-associated atherosclerosis. J Diabetes Res. 2021;2021:2021: p. 6668506.","journal-title":"J Diabetes Res"},{"key":"7075_CR93","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.yjmcc.2024.11.010","volume":"198","author":"Z Xia","year":"2025","unstructured":"Xia Z, et al. TFPI2 hypermethylation promotes diabetic atherosclerosis progression through the Ap2\u03b1\/PPAR\u03b3 axis. J Mol Cell Cardiol. 2025;198:45\u201359.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"7075_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2215-8","volume":"11","author":"P Li","year":"2020","unstructured":"Li P, et al. Loss of PARP-1 attenuates diabetic arteriosclerotic calcification via Stat1\/Runx2 axis. Cell Death Dis. 2020;11(1):22.","journal-title":"Cell Death Dis"},{"issue":"1","key":"7075_CR95","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12967-022-03502-8","volume":"20","author":"J Cao","year":"2022","unstructured":"Cao J, et al. Extracellular vesicle miR-32 derived from macrophage promotes arterial calcification in mice with type 2 diabetes via inhibiting VSMC autophagy. J Transl Med. 2022;20(1):307.","journal-title":"J Transl Med"},{"issue":"1","key":"7075_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02463-y","volume":"22","author":"S Qiu","year":"2024","unstructured":"Qiu S, et al. Targeted delivery of MerTK protein via cell membrane engineered nanoparticle enhances efferocytosis and attenuates atherosclerosis in diabetic ApoE(-\/-) mice. J Nanobiotechnology. 2024;22(1):178.","journal-title":"J Nanobiotechnology"},{"key":"7075_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.118556","volume":"397","author":"WX Liu","year":"2024","unstructured":"Liu WX, et al. Macrophages regulate plaque progression in diabetic Apoe(-\/-) mice dependent on Pi4p\/Nlrp3 signaling pathway. Atherosclerosis. 2024;397:118556.","journal-title":"Atherosclerosis"},{"issue":"12","key":"7075_CR98","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"7075_CR99","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","volume":"103","author":"L Guariguata","year":"2014","unstructured":"Guariguata L, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137\u201349.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"7075_CR100","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.kint.2022.10.030","volume":"103","author":"S Rayego-Mateos","year":"2023","unstructured":"Rayego-Mateos S, et al. Targeting inflammation to treat diabetic kidney disease: the road to 2030. Kidney Int. 2023;103(2):282\u201396.","journal-title":"Kidney Int"},{"issue":"3","key":"7075_CR101","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1440-1797.2006.00576.x","volume":"11","author":"D Nguyen","year":"2006","unstructured":"Nguyen D, et al. Macrophage accumulation in human progressive diabetic nephropathy. Nephrology. 2006;11(3):226\u201331.","journal-title":"Nephrology"},{"issue":"1","key":"7075_CR102","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1523-1755.2004.00367.x","volume":"65","author":"F Chow","year":"2004","unstructured":"Chow F, et al. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int. 2004;65(1):116\u201328.","journal-title":"Kidney Int"},{"issue":"3","key":"7075_CR103","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.dsx.2017.12.028","volume":"12","author":"Z Karimi","year":"2018","unstructured":"Karimi Z, et al. Intercellular adhesion molecule-1 in diabetic patients with and without microalbuminuria. Diabetes Metab Syndr. 2018;12(3):365\u20138.","journal-title":"Diabetes Metab Syndr"},{"issue":"6","key":"7075_CR104","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1681\/ASN.2004070612","volume":"16","author":"FY Chow","year":"2005","unstructured":"Chow FY, et al. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db\/db mice. J Am Soc Nephrol. 2005;16(6):1711\u201322.","journal-title":"J Am Soc Nephrol"},{"key":"7075_CR105","first-page":"179","volume":"3","author":"HF Gu","year":"2012","unstructured":"Gu HF, et al. Association of intercellular adhesion molecule 1 (ICAM1) with diabetes and diabetic nephropathy. Front Endocrinol (Lausanne). 2012;3:179.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"7075_CR106","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/CS20080581","volume":"117","author":"J Niu","year":"2009","unstructured":"Niu J, Kolattukudy PE. Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. Clin Sci (Lond). 2009;117(3):95\u2013109.","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"7075_CR107","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.biocel.2008.07.018","volume":"41","author":"E Melgarejo","year":"2009","unstructured":"Melgarejo E, et al. Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int J Biochem Cell Biol. 2009;41(5):998\u20131001.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"7075_CR108","doi-asserted-by":"publisher","first-page":"F697","DOI":"10.1152\/ajprenal.00016.2008","volume":"294","author":"GH Tesch","year":"2008","unstructured":"Tesch GH. MCP-1\/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol. 2008;294(4):F697-701.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"7075_CR109","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1681\/ASN.2019010068","volume":"30","author":"L Xu","year":"2019","unstructured":"Xu L, Sharkey D, Cantley LG. Tubular GM-CSF promotes late MCP-1\/CCR2-mediated fibrosis and inflammation after ischemia\/reperfusion injury. J Am Soc Nephrol. 2019;30(10):1825\u201340.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"7075_CR110","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/sj.ki.5000014","volume":"69","author":"FY Chow","year":"2006","unstructured":"Chow FY, et al. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int. 2006;69(1):73\u201380.","journal-title":"Kidney Int"},{"issue":"12","key":"7075_CR111","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s00011-020-01411-4","volume":"69","author":"H Zeng","year":"2020","unstructured":"Zeng H, et al. TAB1 regulates glycolysis and activation of macrophages in diabetic nephropathy. Inflamm Res. 2020;69(12):1215\u201334.","journal-title":"Inflamm Res"},{"issue":"8","key":"7075_CR112","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1161\/ATVBAHA.111.228924","volume":"31","author":"S Devaraj","year":"2011","unstructured":"Devaraj S, et al. Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy. Arterioscler Thromb Vasc Biol. 2011;31(8):1796\u2013804.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"7075_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07396-4","volume":"16","author":"S Sunilkumar","year":"2025","unstructured":"Sunilkumar S, et al. REDD1 expression in podocytes facilitates renal inflammation and pyroptosis in streptozotocin-induced diabetic nephropathy. Cell Death Dis. 2025;16(1):79.","journal-title":"Cell Death Dis"},{"issue":"1","key":"7075_CR114","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.kint.2023.09.029","volume":"105","author":"KC Sourris","year":"2024","unstructured":"Sourris KC, et al. Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation. Kidney Int. 2024;105(1):132\u201349.","journal-title":"Kidney Int"},{"key":"7075_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.652558","volume":"8","author":"X Feng","year":"2021","unstructured":"Feng X, et al. PPAR-\u03b1 agonist fenofibrate prevented diabetic nephropathy by inhibiting M1 macrophages via improving endothelial cell function in db\/db mice. Front Med (Lausanne). 2021;8:652558.","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"7075_CR116","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1210\/en.2014-1020","volume":"155","author":"XL Zhang","year":"2014","unstructured":"Zhang XL, et al. Vitamin D prevents podocyte injury via regulation of macrophage M1\/M2 phenotype in diabetic nephropathy rats. Endocrinology. 2014;155(12):4939\u201350.","journal-title":"Endocrinology"},{"key":"7075_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.813979","volume":"13","author":"T Chen","year":"2022","unstructured":"Chen T, et al. ALKBH5-mediated m(6)a modification of A20 regulates microglia polarization in diabetic retinopathy. Front Immunol. 2022;13:813979.","journal-title":"Front Immunol"},{"key":"7075_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.835879","volume":"13","author":"T Ma","year":"2022","unstructured":"Ma T, et al. Excessive activation of Notch signaling in macrophages promote kidney inflammation, fibrosis, and necroptosis. Front Immunol. 2022;13:835879.","journal-title":"Front Immunol"},{"issue":"12","key":"7075_CR119","doi-asserted-by":"publisher","first-page":"F1719","DOI":"10.1152\/ajprenal.00141.2013","volume":"305","author":"H You","year":"2013","unstructured":"You H, et al. Macrophages directly mediate diabetic renal injury. Am J Physiol Renal Physiol. 2013;305(12):F1719\u201327.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"9735","key":"7075_CR120","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124\u201336.","journal-title":"Lancet"},{"key":"7075_CR121","unstructured":"Kollias, A.N. and M.W. Ulbig, Diabetic retinopathy: Early diagnosis and effective treatment. Dtsch Arztebl Int, 2010. 107(5): p. 75\u201383; quiz 84."},{"issue":"13","key":"7075_CR122","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMra1005073","volume":"366","author":"DA Antonetti","year":"2012","unstructured":"Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366(13):1227\u201339.","journal-title":"N Engl J Med"},{"key":"7075_CR123","doi-asserted-by":"publisher","first-page":"100756","DOI":"10.1016\/j.preteyeres.2019.03.002","volume":"72","author":"IM Nawaz","year":"2019","unstructured":"Nawaz IM, et al. Human vitreous in proliferative diabetic retinopathy: characterization and translational implications. Prog Retin Eye Res. 2019;72:100756.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"7075_CR124","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00125-017-4435-8","volume":"61","author":"HP Hammes","year":"2018","unstructured":"Hammes HP. Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond. Diabetologia. 2018;61(1):29\u201338.","journal-title":"Diabetologia"},{"key":"7075_CR125","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/nyas.12412","volume":"1311","author":"SF Abcouwer","year":"2014","unstructured":"Abcouwer SF, Gardner TW. Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment. Ann N Y Acad Sci. 2014;1311:174\u201390.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"7075_CR126","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41574-024-01053-0","volume":"21","author":"DA Antonetti","year":"2025","unstructured":"Antonetti DA, Silva PS, Stitt AW. Publisher correction: current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat Rev Endocrinol. 2025;21(1):62.","journal-title":"Nat Rev Endocrinol"},{"key":"7075_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/cells14050376","author":"H Seo","year":"2025","unstructured":"Seo H, Park SJ, Song M. Diabetic retinopathy (DR): mechanisms, current therapies, and emerging strategies. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14050376.","journal-title":"Cells"},{"key":"7075_CR128","doi-asserted-by":"publisher","DOI":"10.1172\/JCI180904","author":"JK Sterling","year":"2024","unstructured":"Sterling JK, et al. Retinal perivascular macrophages regulate immune cell infiltration during neuroinflammation in mouse models of ocular disease. J Clin Invest. 2024. https:\/\/doi.org\/10.1172\/JCI180904.","journal-title":"J Clin Invest"},{"issue":"3","key":"7075_CR129","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s10787-019-00647-9","volume":"28","author":"BG Spencer","year":"2020","unstructured":"Spencer BG, et al. Pericytes, inflammation, and diabetic retinopathy. Inflammopharmacology. 2020;28(3):697\u2013709.","journal-title":"Inflammopharmacology"},{"key":"7075_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108796","author":"H Ramos","year":"2023","unstructured":"Ramos H, et al. Inflammation: the link between neural and vascular impairment in the diabetic retina and therapeutic implications. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24108796.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"7075_CR131","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","volume":"30","author":"J Tang","year":"2011","unstructured":"Tang J, Kern TS. Inflammation in diabetic retinopathy. Prog Retin Eye Res. 2011;30(5):343\u201358.","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"7075_CR132","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a020537","volume":"7","author":"F Ginhoux","year":"2015","unstructured":"Ginhoux F, Prinz M. Origin of microglia: current concepts and past controversies. Cold Spring Harb Perspect Biol. 2015;7(8):a020537.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"7075_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.564077","volume":"11","author":"UM Kinuthia","year":"2020","unstructured":"Kinuthia UM, Wolf A, Langmann T. Microglia and inflammatory responses in diabetic retinopathy. Front Immunol. 2020;11:564077.","journal-title":"Front Immunol"},{"key":"7075_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111121","volume":"117","author":"T Chen","year":"2024","unstructured":"Chen T, et al. Mm9_circ_014683 regulates microglia polarization through canonical NF\u03baB signaling pathway in diabetic retinopathy. Cell Signal. 2024;117:111121.","journal-title":"Cell Signal"},{"key":"7075_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/cells11182890","author":"AA Abdelrahman","year":"2022","unstructured":"Abdelrahman AA, et al. Systemic administration of pegylated Arginase-1 attenuates the progression of diabetic retinopathy. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11182890.","journal-title":"Cells"},{"key":"7075_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/cells14020085","author":"AM Abu El-Asrar","year":"2025","unstructured":"Abu El-Asrar AM, et al. ADAMTS13 improves endothelial function and reduces inflammation in diabetic retinopathy. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14020085.","journal-title":"Cells"},{"issue":"1","key":"7075_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010015","volume":"25","author":"E Beltramo","year":"2023","unstructured":"Beltramo E, Mazzeo A, Porta M. Release of pro-inflammatory\/angiogenic factors by retinal microvascular cells is mediated by extracellular vesicles derived from M1-activated microglia. Int J Mol Sci. 2023;25(1):15.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7075_CR138","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13098-024-01282-3","volume":"16","author":"Y Wang","year":"2024","unstructured":"Wang Y, et al. Single-cell RNA sequencing reveals roles of unique retinal microglia types in early diabetic retinopathy. Diabetol Metab Syndr. 2024;16(1):49.","journal-title":"Diabetol Metab Syndr"},{"issue":"12","key":"7075_CR139","doi-asserted-by":"publisher","first-page":"E1153","DOI":"10.1152\/ajpendo.00378.2014","volume":"307","author":"K Ma","year":"2014","unstructured":"Ma K, et al. A cross talk between class A scavenger receptor and receptor for advanced glycation end-products contributes to diabetic retinopathy. Am J Physiol Endocrinol Metab. 2014;307(12):E1153\u201365.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"7075_CR140","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.2337\/db23-1015","volume":"73","author":"S Fu","year":"2024","unstructured":"Fu S, et al. M\u00fcller cells harboring exosomal lncRNA OGRU modulate microglia polarization in diabetic retinopathy by serving as miRNA sponges. Diabetes. 2024;73(11):1919\u201334.","journal-title":"Diabetes"},{"key":"7075_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.632132","volume":"12","author":"F Cano-Cano","year":"2021","unstructured":"Cano-Cano F, et al. Anti-inflammatory (M2) response is induced by a sp(2)-iminosugar glycolipid sulfoxide in diabetic retinopathy. Front Immunol. 2021;12:632132.","journal-title":"Front Immunol"},{"issue":"8","key":"7075_CR142","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1167\/iovs.14-16012","volume":"56","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, et al. M2 macrophages enhance pathological neovascularization in the mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2015;56(8):4767\u201377.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"14","key":"7075_CR143","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/iovs.62.14.22","volume":"62","author":"JH Wang","year":"2021","unstructured":"Wang JH, Kumar S, Liu GS. Bulk Gene Expression Deconvolution Reveals Infiltration of M2 Macrophages in Retinal Neovascularization. Invest Ophthalmol Vis Sci. 2021;62(14):22.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"7075_CR144","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1007\/s00125-024-06215-3","volume":"67","author":"M Yamaguchi","year":"2024","unstructured":"Yamaguchi M, et al. Heterotypic macrophages\/microglia differentially contribute to retinal ischaemia and neovascularisation. Diabetologia. 2024;67(10):2329\u201345.","journal-title":"Diabetologia"},{"issue":"1","key":"7075_CR145","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12974-023-02998-1","volume":"20","author":"T Shen","year":"2023","unstructured":"Shen T, et al. Succinate-induced macrophage polarization and RBP4 secretion promote vascular sprouting in ocular neovascularization. J Neuroinflammation. 2023;20(1):308.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"7075_CR146","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","volume":"11","author":"BC Callaghan","year":"2012","unstructured":"Callaghan BC, et al. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521\u201334.","journal-title":"Lancet Neurol"},{"issue":"4","key":"7075_CR147","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s00125-014-3461-z","volume":"58","author":"L \u00d8stergaard","year":"2015","unstructured":"\u00d8stergaard L, et al. The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy. Diabetologia. 2015;58(4):666\u201377.","journal-title":"Diabetologia"},{"issue":"3","key":"7075_CR148","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrneurol.2016.201","volume":"13","author":"NP Gon\u00e7alves","year":"2017","unstructured":"Gon\u00e7alves NP, et al. Schwann cell interactions with axons and microvessels in diabetic neuropathy. Nat Rev Neurol. 2017;13(3):135\u201347.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"7075_CR149","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.2040-1124.2010.00070.x","volume":"2","author":"S Yagihashi","year":"2011","unstructured":"Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: where are we now and where to go? J Diabetes Investig. 2011;2(1):18\u201332.","journal-title":"J Diabetes Investig"},{"issue":"3","key":"7075_CR150","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s00125-004-1663-5","volume":"48","author":"RA Malik","year":"2005","unstructured":"Malik RA, et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia. 2005;48(3):578\u201385.","journal-title":"Diabetologia"},{"issue":"10","key":"7075_CR151","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.2337\/diabetes.52.10.2615","volume":"52","author":"S Thrainsdottir","year":"2003","unstructured":"Thrainsdottir S, et al. Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man. Diabetes. 2003;52(10):2615\u201322.","journal-title":"Diabetes"},{"issue":"5","key":"7075_CR152","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/ane.12474","volume":"133","author":"T Duksal","year":"2016","unstructured":"Duksal T, et al. Role of inflammation in sensory neuropathy in prediabetes or diabetes. Acta Neurol Scand. 2016;133(5):384\u201390.","journal-title":"Acta Neurol Scand"},{"key":"7075_CR153","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910835","author":"P Baum","year":"2021","unstructured":"Baum P, et al. Inflammatory mechanisms in the pathophysiology of diabetic peripheral neuropathy (DN)-new aspects. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms221910835.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"7075_CR154","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11892-016-0727-5","volume":"16","author":"R Pop-Busui","year":"2016","unstructured":"Pop-Busui R, et al. Inflammation as a Therapeutic Target for Diabetic Neuropathies. Curr Diab Rep. 2016;16(3):29.","journal-title":"Curr Diab Rep"},{"key":"7075_CR155","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001111","author":"SS Gylfadottir","year":"2022","unstructured":"Gylfadottir SS, et al. Analysis of macrophages and peptidergic fibers in the skin of patients with painful diabetic polyneuropathy. Neurol Neuroimmunol Neuroinflamm. 2022. https:\/\/doi.org\/10.1212\/NXI.0000000000001111.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"7075_CR156","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1038\/s41598-022-08100-8","volume":"12","author":"BE Hall","year":"2022","unstructured":"Hall BE, et al. Transcriptomic analysis of human sensory neurons in painful diabetic neuropathy reveals inflammation and neuronal loss. Sci Rep. 2022;12(1):4729.","journal-title":"Sci Rep"},{"key":"7075_CR157","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/JPR.S186372","volume":"12","author":"PA Alvarado-V\u00e1zquez","year":"2019","unstructured":"Alvarado-V\u00e1zquez PA, et al. Cytokine production capabilities of human primary monocyte-derived macrophages from patients with diabetes mellitus type 2 with and without diabetic peripheral neuropathy. J Pain Res. 2019;12:69\u201381.","journal-title":"J Pain Res"},{"key":"7075_CR158","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.033647","author":"HW Kan","year":"2018","unstructured":"Kan HW, et al. CD40-mediated HIF-1\u03b1 expression underlying microangiopathy in diabetic nerve pathology. Dis Model Mech. 2018. https:\/\/doi.org\/10.1242\/dmm.033647.","journal-title":"Dis Model Mech"},{"key":"7075_CR159","doi-asserted-by":"publisher","first-page":"7597382","DOI":"10.1155\/2019\/7597382","volume":"2019","author":"JJ Sun","year":"2019","unstructured":"Sun JJ, et al. Infiltration of Blood-Derived Macrophages Contributes to the Development of Diabetic Neuropathy. J Immunol Res. 2019;2019:7597382.","journal-title":"J Immunol Res"},{"key":"7075_CR160","doi-asserted-by":"publisher","DOI":"10.1172\/JCI141964","author":"MK Jha","year":"2021","unstructured":"Jha MK, et al. Macrophage monocarboxylate transporter 1 promotes peripheral nerve regeneration after injury in mice. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI141964.","journal-title":"J Clin Invest"},{"issue":"1","key":"7075_CR161","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11010-020-03923-3","volume":"476","author":"W Ren","year":"2021","unstructured":"Ren W, et al. Long non-coding RNA HCG18 promotes M1 macrophage polarization through regulating the miR-146a\/TRAF6 axis, facilitating the progression of diabetic peripheral neuropathy. Mol Cell Biochem. 2021;476(1):471\u201382.","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"7075_CR162","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14913","volume":"30","author":"Y Li","year":"2024","unstructured":"Li Y, et al. Hyperglycemia-induced Sirt3 downregulation increases microglial aerobic glycolysis and inflammation in diabetic neuropathic pain pathogenesis. CNS Neurosci Ther. 2024;30(8):e14913.","journal-title":"CNS Neurosci Ther"},{"key":"7075_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105392","volume":"155","author":"K Takahashi","year":"2021","unstructured":"Takahashi K, et al. Inhibitory effects of xanthine oxidase inhibitor, topiroxostat, on development of neuropathy in db\/db mice. Neurobiol Dis. 2021;155:105392.","journal-title":"Neurobiol Dis"},{"key":"7075_CR164","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1196\/annals.1333.091","volume":"1043","author":"NE Cameron","year":"2005","unstructured":"Cameron NE, et al. Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes. Ann N Y Acad Sci. 2005;1043:784\u201392.","journal-title":"Ann N Y Acad Sci"},{"key":"7075_CR165","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.160555","author":"S Osonoi","year":"2022","unstructured":"Osonoi S, et al. RAGE activation in macrophages and development of experimental diabetic polyneuropathy. JCI Insight. 2022. https:\/\/doi.org\/10.1172\/jci.insight.160555.","journal-title":"JCI Insight"},{"issue":"3","key":"7075_CR166","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2337\/db12-0632","volume":"62","author":"JK Juranek","year":"2013","unstructured":"Juranek JK, et al. RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice. Diabetes. 2013;62(3):931\u201343.","journal-title":"Diabetes"},{"issue":"9","key":"7075_CR167","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1007\/s11064-021-03365-3","volume":"46","author":"J Tian","year":"2021","unstructured":"Tian J, et al. Toll-like receptor 2 antagonist ameliorates type 2 diabetes mellitus associated neuropathic pain by repolarizing pro-inflammatory macrophages. Neurochem Res. 2021;46(9):2276\u201384.","journal-title":"Neurochem Res"},{"key":"7075_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153640","volume":"90","author":"GL Jin","year":"2021","unstructured":"Jin GL, et al. Koumine modulates spinal microglial M1 polarization and the inflammatory response through the Notch-RBP-J\u03ba signaling pathway, ameliorating diabetic neuropathic pain in rats. Phytomedicine. 2021;90:153640.","journal-title":"Phytomedicine"},{"issue":"2","key":"7075_CR169","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00125-019-05043-0","volume":"63","author":"B Fan","year":"2020","unstructured":"Fan B, et al. Mesenchymal stromal cell-derived exosomes ameliorate peripheral neuropathy in a mouse model of diabetes. Diabetologia. 2020;63(2):431\u201343.","journal-title":"Diabetologia"},{"issue":"12","key":"7075_CR170","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.2337\/db16-1182","volume":"66","author":"XS Liu","year":"2017","unstructured":"Liu XS, et al. Microrna-146a mimics reduce the peripheral neuropathy in type 2 diabetic mice. Diabetes. 2017;66(12):3111\u201321.","journal-title":"Diabetes"},{"key":"7075_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108330","volume":"685","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, et al. IL-35 promotes microglial M2 polarization in a rat model of diabetic neuropathic pain. Arch Biochem Biophys. 2020;685:108330.","journal-title":"Arch Biochem Biophys"},{"key":"7075_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.173874","volume":"894","author":"H Jahan","year":"2021","unstructured":"Jahan H, Choudhary MI. Gliclazide alters macrophages polarization state in diabetic atherosclerosis in vitro via blocking AGE-RAGE\/TLR4-reactive oxygen species-activated NF-k\u03b2 nexus. Eur J Pharmacol. 2021;894:173874.","journal-title":"Eur J Pharmacol"},{"issue":"14","key":"7075_CR173","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1097\/CM9.0000000000000333","volume":"132","author":"X He","year":"2019","unstructured":"He X, et al. Metformin improved oxidized low-density lipoprotein-impaired mitochondrial function and increased glucose uptake involving Akt-AS160 pathway in raw264.7 macrophages. Chin Med J (Engl). 2019;132(14):1713\u201322.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"7075_CR174","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12933-017-0626-3","volume":"16","author":"R Bruen","year":"2017","unstructured":"Bruen R, et al. Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis. Cardiovasc Diabetol. 2017;16(1):143.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"7075_CR175","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s00125-017-4330-3","volume":"60","author":"\u00c1 Vinu\u00e9","year":"2017","unstructured":"Vinu\u00e9 \u00c1, et al. The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype. Diabetologia. 2017;60(9):1801\u201312.","journal-title":"Diabetologia"},{"issue":"6","key":"7075_CR176","doi-asserted-by":"publisher","first-page":"7360","DOI":"10.1096\/fj.201902055R","volume":"34","author":"C Bi","year":"2020","unstructured":"Bi C, et al. Prostaglandin E2 confers protection against diabetic coronary atherosclerosis by stimulating M2 macrophage polarization via the activation of the CREB\/BDNF\/TrkB signaling pathway. FASEB J. 2020;34(6):7360\u201371.","journal-title":"FASEB J"},{"key":"7075_CR177","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijcard.2015.07.044","volume":"199","author":"C Brenner","year":"2015","unstructured":"Brenner C, et al. DPP-4 inhibition ameliorates atherosclerosis by priming monocytes into M2 macrophages. Int J Cardiol. 2015;199:163\u20139.","journal-title":"Int J Cardiol"},{"issue":"5","key":"7075_CR178","doi-asserted-by":"publisher","first-page":"8201","DOI":"10.1002\/jcb.28102","volume":"120","author":"S Sundararajan","year":"2019","unstructured":"Sundararajan S, et al. Sestrin2 regulates monocyte activation through AMPK-mTOR nexus under high-glucose and dyslipidemic conditions. J Cell Biochem. 2019;120(5):8201\u201313.","journal-title":"J Cell Biochem"},{"key":"7075_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174715","volume":"918","author":"E Abdollahi","year":"2022","unstructured":"Abdollahi E, et al. Dapagliflozin exerts anti-inflammatory effects via inhibition of LPS-induced TLR-4 overexpression and NF-\u03baB activation in human endothelial cells and differentiated macrophages. Eur J Pharmacol. 2022;918:174715.","journal-title":"Eur J Pharmacol"},{"key":"7075_CR180","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081704","author":"Y Nakatsu","year":"2017","unstructured":"Nakatsu Y, et al. The SGLT2 inhibitor luseogliflozin rapidly normalizes aortic mRNA levels of inflammation-related but not lipid-metabolism-related genes and suppresses atherosclerosis in diabetic ApoE KO mice. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18081704.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7075_CR181","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1161\/ATVBAHA.117.310291","volume":"38","author":"K Park","year":"2018","unstructured":"Park K, et al. Exogenous insulin infusion can decrease atherosclerosis in diabetic rodents by improving lipids, inflammation, and endothelial function. Arterioscler Thromb Vasc Biol. 2018;38(1):92\u2013101.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"7075_CR182","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12933-025-02603-0","volume":"24","author":"L Liu","year":"2025","unstructured":"Liu L, et al. Bone marrow mesenchymal stem cell-derived extracellular vesicles alleviate diabetes-exacerbated atherosclerosis via AMPK\/mTOR pathway-mediated autophagy-related macrophage polarization. Cardiovasc Diabetol. 2025;24(1):48.","journal-title":"Cardiovasc Diabetol"},{"key":"7075_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110915","volume":"132","author":"W Fan","year":"2020","unstructured":"Fan W, et al. Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: pharmacology and mechanisms. Biomed Pharmacother. 2020;132:110915.","journal-title":"Biomed Pharmacother"},{"key":"7075_CR184","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00464","volume":"9","author":"M Guo","year":"2018","unstructured":"Guo M, et al. Ginsenoside Rg3 mitigates atherosclerosis progression in diabetic apoE-\/- mice by skewing macrophages to the M2 phenotype. Front Pharmacol. 2018;9:464.","journal-title":"Front Pharmacol"},{"key":"7075_CR185","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.metabol.2018.01.010","volume":"83","author":"Y Takahashi","year":"2018","unstructured":"Takahashi Y, et al. Novel phytopeptide osmotin mimics preventive effects of adiponectin on vascular inflammation and atherosclerosis. Metabolism. 2018;83:128\u201338.","journal-title":"Metabolism"},{"key":"7075_CR186","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175039","volume":"926","author":"Q Cui","year":"2022","unstructured":"Cui Q, et al. Matrine inhibits advanced glycation end products-induced macrophage M1 polarization by reducing DNMT3a\/b-mediated DNA methylation of GPX1 promoter. Eur J Pharmacol. 2022;926:175039.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"7075_CR187","doi-asserted-by":"publisher","first-page":"97287","DOI":"10.4239\/wjd.v16.i2.97287","volume":"16","author":"SX Xiong","year":"2025","unstructured":"Xiong SX, et al. Dapagliflozin exerts anti-apoptotic effects by mitigating macrophage polarization via modulation of the phosphoinositide 3-kinase\/protein kinase B signaling pathway. World J Diabetes. 2025;16(2):97287.","journal-title":"World J Diabetes"},{"issue":"5","key":"7075_CR188","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.1002\/jcp.27450","volume":"234","author":"X Zhang","year":"2019","unstructured":"Zhang X, et al. Active vitamin D regulates macrophage M1\/M2 phenotypes via the STAT-1-TREM-1 pathway in diabetic nephropathy. J Cell Physiol. 2019;234(5):6917\u201326.","journal-title":"J Cell Physiol"},{"issue":"20","key":"7075_CR189","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202401489R","volume":"38","author":"S Tang","year":"2024","unstructured":"Tang S, et al. Paricalcitol ameliorates diabetic nephropathy by promoting EETs and M2 macrophage polarization and inhibiting inflammation by regulating VDR\/CYP2J2 axis. FASEB j. 2024;38(20):e70108.","journal-title":"FASEB j"},{"issue":"8","key":"7075_CR190","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.2337\/db15-1413","volume":"65","author":"MG Boels","year":"2016","unstructured":"Boels MG, et al. Atrasentan reduces albuminuria by restoring the glomerular endothelial glycocalyx barrier in diabetic nephropathy. Diabetes. 2016;65(8):2429\u201339.","journal-title":"Diabetes"},{"issue":"1","key":"7075_CR191","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12964-024-01728-1","volume":"22","author":"CL Cliff","year":"2024","unstructured":"Cliff CL, Squires PE, Hills CE. Tonabersat suppresses priming\/activation of the NOD-like receptor protein-3 (NLRP3) inflammasome and decreases renal tubular epithelial-to-macrophage crosstalk in a model of diabetic kidney disease. Cell Commun Signal. 2024;22(1):351.","journal-title":"Cell Commun Signal"},{"issue":"3","key":"7075_CR192","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1436-1","volume":"10","author":"SD Hwang","year":"2019","unstructured":"Hwang SD, et al. Inhibition of lymphatic proliferation by the selective VEGFR-3 inhibitor SAR131675 ameliorates diabetic nephropathy in db\/db mice. Cell Death Dis. 2019;10(3):219.","journal-title":"Cell Death Dis"},{"issue":"1","key":"7075_CR193","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13287-022-02855-7","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. Microrna-146a-5p-modified human umbilical cord mesenchymal stem cells enhance protection against diabetic nephropathy in rats through facilitating M2 macrophage polarization. Stem Cell Res Ther. 2022;13(1):171.","journal-title":"Stem Cell Res Ther"},{"issue":"14","key":"7075_CR194","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202400359R","volume":"38","author":"W Su","year":"2024","unstructured":"Su W, et al. Exosomes derived from umbilical cord-derived mesenchymal stem cells exposed to diabetic microenvironment enhance M2 macrophage polarization and protect against diabetic nephropathy. FASEB j. 2024;38(14):e23798.","journal-title":"FASEB j"},{"issue":"5","key":"7075_CR195","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/stem.3144","volume":"38","author":"Y Yuan","year":"2020","unstructured":"Yuan Y, et al. Mesenchymal stem cells elicit macrophages into M2 phenotype via improving transcription factor EB-mediated autophagy to alleviate diabetic nephropathy. Stem Cells. 2020;38(5):639\u201352.","journal-title":"Stem Cells"},{"issue":"7","key":"7075_CR196","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/stem.3375","volume":"39","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, et al. Mitochondrial transfer from mesenchymal stem cells to macrophages restricts inflammation and alleviates kidney injury in diabetic nephropathy mice via PGC-1\u03b1 activation. Stem Cells. 2021;39(7):913\u201328.","journal-title":"Stem Cells"},{"key":"7075_CR197","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.733808","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, et al. Hyperoside suppresses renal inflammation by regulating macrophage polarization in mice with type 2 diabetes mellitus. Front Immunol. 2021;12:733808.","journal-title":"Front Immunol"},{"key":"7075_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104678","volume":"153","author":"S Yang","year":"2020","unstructured":"Yang S, et al. Tectorigenin attenuates diabetic nephropathy by improving vascular endothelium dysfunction through activating AdipoR1\/2 pathway. Pharmacol Res. 2020;153:104678.","journal-title":"Pharmacol Res"},{"issue":"1","key":"7075_CR199","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4239\/wjd.v15.i1.105","volume":"15","author":"WL Xu","year":"2024","unstructured":"Xu WL, et al. Myricetin induces M2 macrophage polarization to alleviate renal tubulointerstitial fibrosis in diabetic nephropathy via PI3K\/Akt pathway. World J Diabetes. 2024;15(1):105\u201325.","journal-title":"World J Diabetes"},{"key":"7075_CR200","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.2147\/DDDT.S257613","volume":"14","author":"J Han","year":"2020","unstructured":"Han J, et al. Hirudin protects against kidney damage in streptozotocin-induced diabetic nephropathy rats by inhibiting inflammation via P38 MAPK\/NF-\u03baB pathway. Drug Des Devel Ther. 2020;14:3223\u201334.","journal-title":"Drug Des Devel Ther"},{"key":"7075_CR201","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118808","volume":"272","author":"Q Du","year":"2021","unstructured":"Du Q, et al. Loganin alleviates macrophage infiltration and activation by inhibiting the MCP-1\/CCR2 axis in diabetic nephropathy. Life Sci. 2021;272:118808.","journal-title":"Life Sci"},{"key":"7075_CR202","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.biopha.2018.10.060","volume":"109","author":"L Jiandong","year":"2019","unstructured":"Jiandong L, et al. Trichosanthes kirilowii lectin ameliorates streptozocin-induced kidney injury via modulation of the balance between M1\/M2 phenotype macrophage. Biomed Pharmacother. 2019;109:93\u2013102.","journal-title":"Biomed Pharmacother"},{"key":"7075_CR203","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.962606","volume":"13","author":"M Liang","year":"2022","unstructured":"Liang M, et al. Yi-Shen-Hua-Shi granules inhibit diabetic nephropathy by ameliorating podocyte injury induced by macrophage-derived exosomes. Front Pharmacol. 2022;13:962606.","journal-title":"Front Pharmacol"},{"issue":"2","key":"7075_CR204","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.62.2.3","volume":"62","author":"H Li","year":"2021","unstructured":"Li H, et al. Katp opener attenuates diabetic-induced M\u00fcller gliosis and inflammation by modulating Kir6.1 in microglia. Invest Ophthalmol Vis Sci. 2021;62(2):3.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7075_CR205","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.831660","volume":"13","author":"L Tang","year":"2022","unstructured":"Tang L, et al. Melatonin maintains inner blood-retinal barrier by regulating microglia via inhibition of PI3K\/Akt\/Stat3\/NF-\u03baB signaling pathways in experimental diabetic retinopathy. Front Immunol. 2022;13:831660.","journal-title":"Front Immunol"},{"issue":"1","key":"7075_CR206","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12951-024-02330-w","volume":"22","author":"X Wang","year":"2024","unstructured":"Wang X, et al. M2 microglia-derived exosomes promote vascular remodeling in diabetic retinopathy. J Nanobiotechnology. 2024;22(1):56.","journal-title":"J Nanobiotechnology"},{"issue":"3","key":"7075_CR207","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/jdi.14381","volume":"16","author":"X Xi","year":"2025","unstructured":"Xi X, et al. MiR-130a-3p enhances autophagy through the YY1\/PI3K\/AKT\/mTOR signaling pathway to regulate macrophage polarization and alleviate diabetic retinopathy. J Diabetes Investig. 2025;16(3):392\u2013404.","journal-title":"J Diabetes Investig"},{"key":"7075_CR208","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231710184","author":"MC Trotta","year":"2022","unstructured":"Trotta MC, et al. Systemic beta-hydroxybutyrate affects BDNF and autophagy into the retina of diabetic mice. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms231710184.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"7075_CR209","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1007\/s10753-024-02005-6","volume":"47","author":"J Tong","year":"2024","unstructured":"Tong J, et al. Mesenchymal stem cells regulate microglial polarization via inhibition of the HMGB1\/TLR4 signaling pathway in diabetic retinopathy. Inflammation. 2024;47(5):1728\u201343.","journal-title":"Inflammation"},{"key":"7075_CR210","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/srep00076","volume":"1","author":"V Marchetti","year":"2011","unstructured":"Marchetti V, et al. Differential macrophage polarization promotes tissue remodeling and repair in a model of ischemic retinopathy. Sci Rep. 2011;1:76.","journal-title":"Sci Rep"},{"key":"7075_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119567","volume":"277","author":"M Fang","year":"2021","unstructured":"Fang M, et al. Asiatic acid attenuates diabetic retinopathy through TLR4\/MyD88\/NF-\u03baB p65 mediated modulation of microglia polarization. Life Sci. 2021;277:119567.","journal-title":"Life Sci"},{"issue":"30","key":"7075_CR212","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302909","volume":"10","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, et al. Retinal microenvironment-protected Rhein-GFFYE nanofibers attenuate retinal ischemia-reperfusion injury via inhibiting oxidative stress and regulating microglial\/macrophage M1\/M2 polarization. Adv Sci (Weinh). 2023;10(30):e2302909.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"7075_CR213","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3344\/kjp.24244","volume":"38","author":"W Wei","year":"2025","unstructured":"Wei W, et al. Temporal therapy utilizing exosomes derived from M2 macrophages demonstrates enhanced efficacy in alleviating neuropathic pain in diabetic rats. Korean J Pain. 2025;38(1):14\u201328.","journal-title":"Korean J Pain"},{"issue":"4","key":"7075_CR214","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/jdi.12452","volume":"7","author":"M Omi","year":"2016","unstructured":"Omi M, et al. Transplantation of dental pulp stem cells suppressed inflammation in sciatic nerves by promoting macrophage polarization towards anti-inflammation phenotypes and ameliorated diabetic polyneuropathy. J Diabetes Investig. 2016;7(4):485\u201396.","journal-title":"J Diabetes Investig"},{"key":"7075_CR215","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118442","volume":"333","author":"S Wang","year":"2024","unstructured":"Wang S, et al. Jinmaitong alleviates diabetic neuropathic pain by inhibiting JAK2\/STAT3 signaling in microglia of diabetic rats. J Ethnopharmacol. 2024;333:118442.","journal-title":"J Ethnopharmacol"},{"key":"7075_CR216","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.790405","volume":"12","author":"JK Jensen","year":"2021","unstructured":"Jensen JK, et al. Effect of 26 weeks of Liraglutide treatment on coronary artery inflammation in type 2 diabetes quantified by [(64)Cu]Cu-DOTATATE PET\/CT: results from the LIRAFLAME trial. Front Endocrinol (Lausanne). 2021;12:790405.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"7075_CR217","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.metabol.2012.09.004","volume":"62","author":"N Satoh-Asahara","year":"2013","unstructured":"Satoh-Asahara N, et al. A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients. Metabolism. 2013;62(3):347\u201351.","journal-title":"Metabolism"},{"key":"7075_CR218","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.117529","volume":"392","author":"RS Rosenson","year":"2024","unstructured":"Rosenson RS, et al. Inhibition of PCSK9 with evolocumab modulates lipoproteins and monocyte activation in high-risk ASCVD subjects. Atherosclerosis. 2024;392:117529.","journal-title":"Atherosclerosis"},{"issue":"11","key":"7075_CR219","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1161\/CIRCRESAHA.115.306884","volume":"118","author":"JA Beckman","year":"2016","unstructured":"Beckman JA, Creager MA. Vascular complications of diabetes. Circ Res. 2016;118(11):1771\u201385.","journal-title":"Circ Res"},{"key":"7075_CR220","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.freeradbiomed.2019.11.002","volume":"146","author":"L Azul","year":"2020","unstructured":"Azul L, et al. Increased inflammation, oxidative stress and a reduction in antioxidant defense enzymes in perivascular adipose tissue contribute to vascular dysfunction in type 2 diabetes. Free Radic Biol Med. 2020;146:264\u201374.","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"7075_CR221","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1210\/jc.2008-2534","volume":"94","author":"RB Goldberg","year":"2009","unstructured":"Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab. 2009;94(9):3171\u201382.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"7075_CR222","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.tcm.2010.12.002","volume":"20","author":"BK Tan","year":"2010","unstructured":"Tan BK, Adya R, Randeva HS. Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc Med. 2010;20(5):143\u20138.","journal-title":"Trends Cardiovasc Med"},{"key":"7075_CR223","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101932","volume":"41","author":"X Ge","year":"2021","unstructured":"Ge X, et al. Exosomal miR-155 from M1-polarized macrophages promotes EndoMT and impairs mitochondrial function via activating NF-\u03baB signaling pathway in vascular endothelial cells after traumatic spinal cord injury. Redox Biol. 2021;41:101932.","journal-title":"Redox Biol"},{"issue":"5","key":"7075_CR224","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70458","volume":"29","author":"Y Li","year":"2025","unstructured":"Li Y, et al. Macrophage A2aR Alleviates LPS-Induced Vascular Endothelial Injury and Inflammation via Inhibiting M1 Polarisation and Oxidative Stress. J Cell Mol Med. 2025;29(5):e70458.","journal-title":"J Cell Mol Med"},{"key":"7075_CR225","doi-asserted-by":"publisher","first-page":"1549484","DOI":"10.3389\/fimmu.2025.1549484","volume":"16","author":"W Yu","year":"2025","unstructured":"Yu W, et al. Targeting lipid metabolic reprogramming to alleviate diabetic kidney disease: molecular insights and therapeutic strategies. Front Immunol. 2025;16:1549484.","journal-title":"Front Immunol"},{"key":"7075_CR226","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103449","volume":"79","author":"QY Zhang","year":"2025","unstructured":"Zhang QY, et al. Macrophage metabolic reprogramming ameliorates diabetes-induced microvascular dysfunction. Redox Biol. 2025;79:103449.","journal-title":"Redox Biol"},{"issue":"Special Issue","key":"7075_CR227","doi-asserted-by":"publisher","first-page":"58","DOI":"10.62476\/abes9s58","volume":"9","author":"N Erdil","year":"2024","unstructured":"Erdil N. Cardiovascular disease, signaling, gene\/cell therapy and advanced nanobiomaterials. Advances in Biology & Earth Sciences. 2024;9(Special Issue):58\u201380.","journal-title":"Advances in Biology & Earth Sciences"},{"key":"7075_CR228","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/816460","volume":"2015","author":"T R\u0151szer","year":"2015","unstructured":"R\u0151szer T. Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms. Mediators Inflamm. 2015;2015:816460.","journal-title":"Mediators Inflamm"},{"issue":"4","key":"7075_CR229","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41569-021-00629-x","volume":"19","author":"W Chen","year":"2022","unstructured":"Chen W, et al. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis. Nat Rev Cardiol. 2022;19(4):228\u201349.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"7075_CR230","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12974-018-1238-x","volume":"15","author":"AH Sikkema","year":"2018","unstructured":"Sikkema AH, et al. Fibronectin aggregates promote features of a classically and alternatively activated phenotype in macrophages. J Neuroinflammation. 2018;15(1):218.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"7075_CR231","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nri.2017.90","volume":"18","author":"RL Gieseck 3rd","year":"2018","unstructured":"Gieseck RL 3rd, Wilson MS, Wynn TA. Type 2 immunity in tissue repair and fibrosis. Nat Rev Immunol. 2018;18(1):62\u201376.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"7075_CR232","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/JLB.3RU1018-378RR","volume":"106","author":"LX Wang","year":"2019","unstructured":"Wang LX, et al. M2b macrophage polarization and its roles in diseases. J Leukoc Biol. 2019;106(2):345\u201358.","journal-title":"J Leukoc Biol"},{"issue":"7","key":"7075_CR233","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.4049\/jimmunol.1200662","volume":"189","author":"G Zizzo","year":"2012","unstructured":"Zizzo G, et al. Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunol. 2012;189(7):3508\u201320.","journal-title":"J Immunol"},{"issue":"6","key":"7075_CR234","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/cr.2010.52","volume":"20","author":"Q Wang","year":"2010","unstructured":"Wang Q, et al. Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages. Cell Res. 2010;20(6):701\u201312.","journal-title":"Cell Res"},{"issue":"7","key":"7075_CR235","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.imbio.2017.02.006","volume":"222","author":"EB Lurier","year":"2017","unstructured":"Lurier EB, et al. Transcriptome analysis of IL-10-stimulated (M2c) macrophages by next-generation sequencing. Immunobiology. 2017;222(7):847\u201356.","journal-title":"Immunobiology"},{"issue":"5","key":"7075_CR236","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1210\/en.2010-1312","volume":"152","author":"S Fujisaka","year":"2011","unstructured":"Fujisaka S, et al. Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization in high-fat-fed mice. Endocrinology. 2011;152(5):1789\u201399.","journal-title":"Endocrinology"},{"key":"7075_CR237","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105750","volume":"75","author":"SH Choe","year":"2019","unstructured":"Choe SH, et al. Telmisartan, an angiotensin II receptor blocker, attenuates Prevotella intermedia lipopolysaccharide-induced production of nitric oxide and interleukin-1\u03b2 in murine macrophages. Int Immunopharmacol. 2019;75:105750.","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"7075_CR238","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1080\/15384047.2020.1838032","volume":"21","author":"Y Wang","year":"2020","unstructured":"Wang Y, et al. Obesity and metabolic syndrome related macrophage promotes PD-L1 expression in TNBC through IL6\/JAK\/STAT pathway and can be reversed by telmisartan. Cancer Biol Ther. 2020;21(12):1179\u201390.","journal-title":"Cancer Biol Ther"},{"key":"7075_CR239","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25225426","author":"A Ehmedah","year":"2020","unstructured":"Ehmedah A, et al. Effect of vitamin B complex treatment on macrophages to Schwann cells association during neuroinflammation after peripheral nerve injury. Molecules. 2020. https:\/\/doi.org\/10.3390\/molecules25225426.","journal-title":"Molecules"},{"key":"7075_CR240","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114620","volume":"155","author":"H Duan","year":"2025","unstructured":"Duan H, et al. Nicotinamide mononucleotide ameliorates hypertriglyceridemia pancreatitis via NAD(+)\/SIRT1-mediated TXNIP suppression and NOTCH pathway for accelerated repair-associated processes. Int Immunopharmacol. 2025;155:114620.","journal-title":"Int Immunopharmacol"},{"key":"7075_CR241","doi-asserted-by":"crossref","unstructured":"Zhang, K., et al., Corrigendum to \"Liraglutide attenuates angiotensin II-induced aortic dissection and aortic aneurysm via inhibiting M1 macrophage polarization in APOE -\/- mice\" [Biochem. Pharmacol. 223 (2024) 116170]. Biochem Pharmacol, 2025. 232: p. 116707.","DOI":"10.1016\/j.bcp.2024.116707"},{"key":"7075_CR242","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1544684","volume":"16","author":"X Hu","year":"2025","unstructured":"Hu X, Li Y, Liu X. Sitagliptin phosphate ameliorates chronic inflammation in diabetes mellitus via modulating macrophage polarization. Front Endocrinol (Lausanne). 2025;16:1544684.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7075_CR243","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113730","volume":"145","author":"L Quadros-Pereira","year":"2025","unstructured":"Quadros-Pereira L, et al. Treatment with sitagliptin exacerbates the M2 phenotype in macrophages in vitro. Int Immunopharmacol. 2025;145:113730.","journal-title":"Int Immunopharmacol"},{"key":"7075_CR244","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110078","volume":"126","author":"G Xiang","year":"2020","unstructured":"Xiang G, et al. The impact of sitagliptin on macrophage polarity and angiogenesis in the osteointegration of titanium implants in type 2 diabetes. Biomed Pharmacother. 2020;126:110078.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"7075_CR245","first-page":"2740","volume":"19","author":"C Zhang","year":"2019","unstructured":"Zhang C, et al. Pioglitazone increases VEGFR3 expression and promotes activation of M2 macrophages via the peroxisome proliferator-activated receptor \u03b3. Mol Med Rep. 2019;19(4):2740\u20138.","journal-title":"Mol Med Rep"},{"issue":"11","key":"7075_CR246","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1161\/CIRCRESAHA.121.320056","volume":"131","author":"S Katsuki","year":"2022","unstructured":"Katsuki S, et al. Proprotein convertase subtilisin\/kexin 9 (PCSK9) promotes macrophage activation via LDL receptor-independent mechanisms. Circ Res. 2022;131(11):873\u201389.","journal-title":"Circ Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07075-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07075-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07075-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:05:24Z","timestamp":1759493124000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07075-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":246,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7075"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07075-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"12 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"1050"}}